Method for fenbendazole encapsulation

FIELD: medicine, pharmaceutics.

SUBSTANCE: invention refers to chemical-pharmaceutical industry and represents a method for drug encapsulation by non-solvent addition; the method is characterised by the fact that the above drug is presented by fenbendazole, while a coating is sodium carboxymethyl cellulose precipitated from an acetone solution by adding butanol as a non-solvent and water at 25C.

EFFECT: invention provides simplifying and accelerating the microencapsulation process, reducing the microencapsulation loss (higher weight yield).

3 ex

 

The invention relates to the field of encapsulation, and in particular the production of microcapsules of fenbendazol.

Previously known methods for producing microcapsules of drugs. Thus, in U.S. Pat. 2092155 IPC A61K 047/02, A61K 009/16 published 10.10.1997, Russian Federation, proposed a method for microencapsulation of drugs, based on the use of irradiation with ultraviolet rays.

The disadvantages of this method are the duration of the process and the use of ultraviolet radiation, which can influence the formation of microcapsules.

In Pat. 2091071 IPC AC/10, the Russian Federation, published 27.09.1997, method for obtaining the drug by dispersion in a ball mill to obtain microcapsules.

The disadvantage of this method is the use of a ball mill and the duration of the process.

In Pat. 2101010 IPC AC 9/52, AK 9/50, AK 9/22, AK 9/20, AK 31/19, Russian Federation, published 10.01.1998 proposed chewable form of the drug with taste masking, having the properties of a controlled release drug product that contains microcapsules with a size of 100-800 microns in diameter and consists of pharmaceutical kernel crystalline ibuprofen and polymeric coating comprising a plasticizer, elastic enough to resist chewing. Polymers the e coating is a copolymer based on methacrylic acid.

The drawbacks of the invention: use of a copolymer based on methacrylic acid, as these polymer coatings can cause cancer; complexity; the duration of the process.

In Pat. 2173140 IPC AC 009/50, AK 009/127, Russian Federation, published 10.09.2001, method for obtaining kremnijorganicheskih microcapsules using a rotary cavitation plants with high shear effort and powerful acoustic phenomena of sound and ultrasound range for dispersion.

The disadvantage of this method is the use of special equipment - rotary-quotational installation, which has ultrasonic action that affects the formation of microcapsules and can cause adverse reactions due to the fact that ultrasound destructive effect on the polymers of protein nature, therefore the proposed method is applicable when working with polymers of synthetic origin.

In Pat. 2359662 IPC AC 009/56, A61J 003/07, B01J 013/02, A23L 001/00 published 27.06.2009, Russian Federation, proposed a method of producing microcapsules using spray cooling in the spray tower Niro under the following conditions: air temperature at the inlet 10C, the temperature at the outlet 28C, the speed of rotation of the spray drum 10000 s is s/min Microcapsules according to the invention have improved stability and provide adjustable and/or prolonged release of the active ingredient.

Disadvantages of the proposed method are the duration of the process and the use of special equipment, a set of conditions (temperature of inlet air 10C, the temperature at the outlet 28C, the speed of rotation of the spray drum 10000 rpm).

The closest method is the method proposed in U.S. Pat. 2134967 IPC A01N 53/00, A01N 25/28 published 27.08.1999,, Russian Federation (1999). Water is dispersed solution of a mixture of natural lipids and a PYRETHROID insecticide in the weight ratio of 2-4:1 in an organic solvent, which leads to simplification of the method of microencapsulation.

The disadvantage of this method is the dispersion in the aquatic environment, which makes the proposed method applicable to the production of microcapsules of water-soluble drugs in water-soluble polymers.

The technical objective is the simplification and acceleration of the process of production of microcapsules, the reduction of losses upon receipt of the microcapsules (increase in mass).

The solution of the technical problem is achieved by the method of encapsulation of fenbendazol, characterized in that as the shell of the microcapsules used sodium carboxymethylcellulose when receiving physical-x the chemical deposition method nerastvorim using two precipitators - butanol and acetone, the retrieval process is carried out without special equipment.

A distinctive feature of the proposed method is the use of sodium carboxymethylcellulose as the shell of the microcapsules of fenbendazol as their cores, and the use of two precipitators - butanol and acetone.

The result of the proposed method are obtaining microcapsules of fenbendazol in the sodium carboxymethyl cellulose at 25C for 20 minutes. The output of the microcapsules is over 90%.

EXAMPLE 1 Obtaining microcapsules of fenbendazol with the dissolution of the drug in dioxane, the ratio of the core/polymer 1:3

100 mg of fenbendazol dissolved in 1 ml of dioxane and the resulting mixture was dispersed in a solution of sodium carboxymethyl cellulose in acetone, containing the specified 300 mg of the polymer in the presence of 0.01 drug A with when mixing about 1000/sec. Then poured 2 ml of butanol and 1 ml of distilled water. The resulting suspension is filtered and dried at room temperature.

Received 0,396 g white to yellowish powder. The yield was 99%.

EXAMPLE 2 Obtaining microcapsules of fenbendazol with the dissolution of the drug in dimethyl sulfoxide (DMSO), the ratio of the core/polymer 1:3

100 mg of fenbendazol dissolved in 1 ml DMSO and the mixture was dispersed in a solution of sodium carboxymethylcellulose in the cetone, containing the specified 300 mg of the polymer in the presence of 0.01 drug A with when mixing about 1000/sec. Then poured 2 ml of butanol and 1 ml of distilled water. The resulting suspension is filtered and dried at room temperature.

Received 0,396 g white to yellowish powder. The yield was 99%.

EXAMPLE 3 Obtaining microcapsules of fenbendazol with the dissolution of the drug in dimethylformamide (DMF), the ratio of the core/polymer 1:3

100 mg of fenbendazol dissolved in 1 ml DMF and the resulting mixture was dispersed in a solution of sodium carboxymethyl cellulose in acetone, containing the specified 300 mg of the polymer in the presence of 0.01 drug A with when mixing about 1000/sec. Then poured 2 ml of butanol and 1 ml of distilled water. The resulting suspension is filtered and dried at room temperature.

Received 0,396 g white to yellowish powder. The yield was 99%.

The obtained microcapsules of fenbendazol physico-chemical method for the deposition nerastvorim using two precipitators - butanol and acetone, which increases output and accelerates the process of microencapsulation. The process is simple to perform and lasts for 20 minutes, requires no special equipment.

The proposed method is suitable for the veterinary industry due to the minimal loss of speed, prettypretty and allocation of microcapsules.

The method of encapsulation of a medicinal product by precipitation with aristotelem, characterized in that the medicinal product is used fenbendazol, as the shell - sodium carboxymethylcellulose, which is precipitated from a solution in acetone by adding as herstories butanol and water at 25C.



 

Same patents:

FIELD: medicine, pharmaceutics.

SUBSTANCE: invention refers to chemical-pharmaceutical industry and represents a method for drug encapsulation by non-solvent addition; the method is characterised by the fact that the above drug is presented by cephalosporin preparations, while a coating is Poludanum precipitated from an aqueous solution by adding ethanol as a non-solvent and acetone at 25C.

EFFECT: invention provides simplifying and accelerating the microencapsulation process, reducing the microencapsulation loss (higher weight yield).

3 ex

FIELD: medicine, pharmaceutics.

SUBSTANCE: invention refers to chemical-pharmaceutical industry and represents a method for drug microencapsulation by non-solvent addition; the method is characterised by the fact that the above drugs are presented by cephalosporin preparations, while a coating is human serum albumin precipitated from an aqueous solution by adding methylcarbinol as a non-solvent and acetone at 25C.

EFFECT: invention provides simplifying and accelerating the microencapsulation process, reducing the microencapsulation loss (higher weight yield).

3 ex

FIELD: medicine, pharmaceutics.

SUBSTANCE: invention refers to chemical-pharmaceutical industry and represents a method for drug encapsulation by non-solvent addition; the method is characterised by the fact that the above drug is presented by fenbendazole, while a coating is sodium carboxymethyl cellulose precipitated from a butanol solution by adding methylcarbinol as a non-solvent and water at 25C.

EFFECT: invention provides simplifying and accelerating the microencapsulation process, reducing the microencapsulation loss (higher weight yield).

3 ex

FIELD: medicine, pharmaceutics.

SUBSTANCE: invention refers to chemical-pharmaceutical industry and represents a method for drug encapsulation by non-solvent addition; the method is characterised by the fact that the above drug is presented by fenbendazole, while a coating is sodium carboxymethyl cellulose precipitated from a toluene solution by adding butanol as a non-solvent and water at 25C.

EFFECT: invention provides simplifying and accelerating the microencapsulation process, reducing the microencapsulation loss (higher weight yield).

3 ex

FIELD: medicine, pharmaceutics.

SUBSTANCE: invention refers to chemical-pharmaceutical industry and represents a method for preparing drug microcapsules by nonsolvent addition differing by the fact that the drugs represent the preparations of cephalosporin group, and a coating is poludan deposited from an aqueous solution by adding diethyl ester and isopropanol at 25 C as a nonsolvent.

EFFECT: invention provides simplifying and accelerating the process of microcapsules, reducing the microcapsule loss (higher weight yield).

3 ex

FIELD: chemistry.

SUBSTANCE: invention represents method of encapsulating medication by method of sedimentation with non-solvent, characterised by the fact that as medication used is fenbendazole, as coating - sodium carboxymethylcellulose, which is precipitated from solution in acetone by addition of water as non-solvent at 25C.

EFFECT: simplification and acceleration of the process of obtaining microcapsules, reduced loss in obtaining microcapsules.

3 ex

FIELD: chemistry.

SUBSTANCE: invention represents method of encapsulating medication by method of sedimentation with non-solvent, characterised by the fact that as medication used is fenbendazole, as coating - sodium carboxymethylcellulose, which is precipitated from solution in acetone by addition of isopropanol as non-solvent and water at 25C.

EFFECT: simplification and acceleration of the process of obtaining microcapsules, reduced loss in obtaining microcapsules.

3 ex

FIELD: chemistry.

SUBSTANCE: as medical preparation applied is fenbendazole, as envelope- sodium carboxymethylcellulose, which is precipitated from solution in dichloromethane by addition as non-solvent butanol and water at 25C.

EFFECT: simplification and acceleration of the process obtaining microcapsules, reduction of loss in the process of obtaining microcapsules.

3 ex

FIELD: chemistry.

SUBSTANCE: invention relates to the field of encapsulation and represents a method of obtaining microcapsules, possessing supramolecular properties, by a method of precipitation with a non-solvent, in accordance to which a flavouring agent "paprika", used as a nucleus of the microcapsules, is dissolved in butanol, with further dispersion of the obtained mixture in a solution of a fat-soluble polymer, used as a microcapsule envelope, in isopropanol in the presence of E472c.

EFFECT: invention provides simplification and acceleration of the process of obtaining the microcapsules, reduction of loss in the process of obtaining the microcapsules (increase of the output by weight).

2 ex, 1 dwg

FIELD: food industry.

SUBSTANCE: invention relates to the field of flavouring agents microencapsulation and represents a method for production of microcapsules having supramolecular properties by way of sedimentation with a nonsolvent; the method is as follows: "coffee" flavouring agent used as microcapsules core is dissolved in ethanol; then the produced mixture is dispersed in a suspension of sodium-carboxymethyl cellulose, used as microcapsule shell, in acetone in the presence of E472c.

EFFECT: invention ensures simplification and acceleration of the process of microcapsules production and weight yield increase.

2 ex, 2 dwg

FIELD: medicine, pharmaceutics.

SUBSTANCE: invention refers to chemical-pharmaceutical industry and represents a method for drug encapsulation by non-solvent addition; the method is characterised by the fact that the above drug is presented by cephalosporin preparations, while a coating is Poludanum precipitated from an aqueous solution by adding ethanol as a non-solvent and acetone at 25C.

EFFECT: invention provides simplifying and accelerating the microencapsulation process, reducing the microencapsulation loss (higher weight yield).

3 ex

FIELD: chemistry.

SUBSTANCE: method represents physico-chemical of precipitation with non-solvent, in which as microcapsule envelope xanthan gum, as core - ADS 2 fraction, and as precipitating agent - benzene are used.

EFFECT: simplification and acceleration of the process of obtaining microcapsules and increase of output by their weight.

3 dwg, 3 ex

FIELD: medicine, pharmaceutics.

SUBSTANCE: invention refers to chemical-pharmaceutical industry and represents a method for drug microencapsulation by non-solvent addition; the method is characterised by the fact that the above drugs are presented by cephalosporin preparations, while a coating is human serum albumin precipitated from an aqueous solution by adding methylcarbinol as a non-solvent and acetone at 25C.

EFFECT: invention provides simplifying and accelerating the microencapsulation process, reducing the microencapsulation loss (higher weight yield).

3 ex

FIELD: medicine, pharmaceutics.

SUBSTANCE: invention refers to chemical-pharmaceutical industry and represents a method for drug encapsulation by non-solvent addition; the method is characterised by the fact that the above drug is presented by fenbendazole, while a coating is sodium carboxymethyl cellulose precipitated from a butanol solution by adding methylcarbinol as a non-solvent and water at 25C.

EFFECT: invention provides simplifying and accelerating the microencapsulation process, reducing the microencapsulation loss (higher weight yield).

3 ex

FIELD: medicine, pharmaceutics.

SUBSTANCE: invention refers to chemical-pharmaceutical industry and represents a method for drug encapsulation by non-solvent addition; the method is characterised by the fact that the above drug is presented by fenbendazole, while a coating is sodium carboxymethyl cellulose precipitated from a toluene solution by adding butanol as a non-solvent and water at 25C.

EFFECT: invention provides simplifying and accelerating the microencapsulation process, reducing the microencapsulation loss (higher weight yield).

3 ex

FIELD: chemistry.

SUBSTANCE: invention relates to field of microcapsulation of heterocyclic compounds of triazine series. Method of obtaining microcapsules of triazine series pesticides is characterised by the fact that 0.1 g of triazine series pesticide and 0.02 g of E472c preparation as emulsifying agent are added to 10 g of 5% water solution of polyvinyl alcohol (PVA) and obtained mixture is subjected to mixing. Reaction mixture components are dissolved until transparent solution is formed after which 5 ml of carbinol as the first precipitating agent and then 10 ml of isopropanol as the second precipitating agent are added slowly drop-by-drop. After that, obtained suspension of microcapsules is kept for 1 minute, filtered on filter, washed with propanol several times, dried, with method being realised at 25C without special equipment.

EFFECT: simplification of the process of obtaining microcapsules and increase output by weight.

3 ex

FIELD: medicine, pharmaceutics.

SUBSTANCE: invention refers to chemical-pharmaceutical industry and represents a method for preparing drug microcapsules by nonsolvent addition differing by the fact that the drugs represent the preparations of cephalosporin group, and a coating is poludan deposited from an aqueous solution by adding diethyl ester and isopropanol at 25 C as a nonsolvent.

EFFECT: invention provides simplifying and accelerating the process of microcapsules, reducing the microcapsule loss (higher weight yield).

3 ex

FIELD: chemistry.

SUBSTANCE: method of obtaining microcapsules of triazine series pesticides is characterised by the following: 0.1 g of triazine series pesticide and 0.02 g of E472c preparation as emulsifier are added to 10 g of 5% water solution of polyvinyl alcohol (PVA), and obtained mixture is subjected to mixing. After dissolution of reaction mixture components and formation of transparent solution 15 ml of isopropanol are very slowly drop-by-drop poured in, and obtained suspension of microcapsules is stayed for 1 minute, filtered on filter, washed several times with isopropanol and dried. Method is realised at 25C without special equipment.

EFFECT: simplification of the process of obtaining microcapsules and increased output by mass.

3 ex

FIELD: chemistry.

SUBSTANCE: method is characterised by the fact that 100 mg of iron sulphate or zinc sulphate are dissolved in 1 ml of water and obtained mixture is dispersed into carrageenan solution in acetone, which contains 300 mg of carrageenan, in presence of 0.01 g of E472c preparation with mixing. After that, 2 ml of ethanol are added, obtained suspension is filtered and dried at room temperature, with realisation of the method without special equipment.

EFFECT: simplification and acceleration of the process of obtaining microcapsules and increase of output by mass.

2 ex

FIELD: chemistry.

SUBSTANCE: method is characterised by the fact that 100 mg of iron sulphate of zinc sulphate are dissolved in 1 ml of water and obtained mixture is dispersed into solution of kappa-karrageenan in dioxane, which contains 300 mg of kappa-karrageenan, in presence of 0.01 g of E472c preparation with mixing. After that, 2 ml of methylcarbinol are poured in, obtained suspension is filtered and dried at room temperature, with realisation of the method without special equipment.

EFFECT: simplification and acceleration of the process of obtaining microcapsules and increased output by mass.

2 ex

FIELD: medicine, pharmaceutics.

SUBSTANCE: invention refers to chemical-pharmaceutical industry and represents a method for drug encapsulation by non-solvent addition; the method is characterised by the fact that the above drug is presented by fenbendazole, while a coating is sodium carboxymethyl cellulose precipitated from a butanol solution by adding methylcarbinol as a non-solvent and water at 25C.

EFFECT: invention provides simplifying and accelerating the microencapsulation process, reducing the microencapsulation loss (higher weight yield).

3 ex

Up!